Anti-platelet agents were given to 36% of these T2D
patients and this was significantly associated with the presence of CAD ([chi square] =31.
Our aim was to assess the prevalence of BED among individuals with T2D
and to investigate whether a comorbidity with BED would affect glycemic control in these individuals.
The past decade has seen a steady increase in cases of pediatric T2D
in the United States, predominantly among African Americans and other ethnic minorities.
Clinical trials have documented the role that hyperglycemia plays in the risk of microvascular complications in patients with T1D and T2D
(17-22), and have demonstrated the effectiveness of blood glucose control to reduce the risk of diabetic retinopathy.
We investigated the possibility to use the ratios of the levels of TC/HDL-C, TG/HDL-C, LDL-C/HDL-C as well as the levels of CRF, non-HDL-C, LDL-C, TC, and TG, and the WC as surrogates for the estimation of insulin levels and insulin resistance in T2D
In addition, the data confirmed that proportional effects of canagliflozin compared to placebo were comparable across a broad population of patients with T2D
at high CV risk.
org/) Diabetologia, the journal of the European Association for the Study of Diabetes, was based on data of over 740,000 individuals with T2D
Inclusion criteria were that the partner diagnosed with T2D
was in poor glycemic control (glycated hemoglobin [HbA1c] [greater than or equal to] 7.
It can serve as an alternative means for glycemic control, since the insulin-dependent pathway is already impaired in T2D
Given the dimensions of the diabetes epidemic on a global scale, particularly, the rising prevalence of T2D
in Venezuela (13-15), it is critical that various drivers for T2D
, especially those that have been un- or under-recognized, are better understood to fashion successful preventive measures.
As for T2D
related to renal involvement, there were three pathological types: DKD, nondiabetic renal disease (NDRD), and DKD superimposed on NDRD.
ECG monitoring also showed significantly lower very low frequency power in those with a family history of diabetes, "indicating that reduced vagal activation potentially could be an early component in the development of T2D